Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Steglich Rearrangement. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102329281A details a novel asymmetric Steglich rearrangement for C-acyl azlactones, offering high enantioselectivity and cost-effective manufacturing for pharmaceutical intermediates.
Novel 3,4-diaminopyridine catalyst enables high-yield asymmetric synthesis. Offers supply chain stability and cost efficiency for pharmaceutical intermediate manufacturing processes globally.